title: [Evaluation of the cost of non-hormonal treatment of osteoporosis].
abstract: Osteoporosis is a disease affecting a large population of postmenopausal women. The treatment is given for a period of 5, 10, 20 years.... The cost of the treatment plays an important role in the field of health economy. A commercial form of calcium and vitamin D for 10 years represent for the patient a cost of 50,000 BF. The other treatments, alternative to hormonal substitution, have variable prices, for biphosphonates, 50,000 to 500,000 for the insurance and from 1,000 to 5,000 BF for the patient having a regular insurance. A comprehensive choice in long term treatment should take into account efficacy and cost of the treatment.
authors.affiliation: Clinique de Rhumatologie, Département de Médecine Interne, C.H.U. Brugmann, U.L.B.
authors.forename: A
authors.initials: A
authors.lastname: Peretz
mesh_terms: D002116:Calcitonin / Q000191:economics* / Q000627:therapeutic use; D002118:Calcium / Q000191:economics* / Q000627:therapeutic use; D004164:Diphosphonates / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs; D005260:Female; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D018579:Patient Selection; D014807:Vitamin D / Q000191:economics* / Q000627:therapeutic use
chemical_list: D004164:Diphosphonates; D014807:Vitamin D; D002116:Calcitonin; D002118:Calcium